Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2021 | Improving the stratification of prostate cancer

Alistair Grey, FRCS (Urol), University College London, London, UK, discusses the ongoing efforts in prostate cancer to improve stratification using newer biomarkers. A more accurate stratification model may enable less invasive treatment of men with less aggressive disease. Dr Grey also highlights the potential of improved stratification to identify more patients suitable for active surveillance. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Disclosures

Alistair Grey, FRCS (Urol) has received travel and accommodation for training in the use of irreversible electroporation from Angiodynamics Ltd who manufacture the Nanoknife.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.